The Application of Metabolomics in Hyperlipidemia: Insights into Biomarker Discovery and Treatment Efficacy Assessment
Metabolites · 06.08.2024 · 14 (8) · 438
DOI: 10.3390/metabo14080438 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Metabolites, online erschienen am 06.08.2024. Verfasst von Mohammad Alwahsh und 4 weiteren Autor:innen. Beteiligte Einrichtung: Faculty of Pharmacy, Al-Zaytoonah University of Jordan, Amman 17138, Jordan. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 98 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Al-Zaytoonah University of Jordan.
Abstract (Originalsprache)
Hyperlipidemia is a lipid metabolism disorder that refers to increased levels of total triglycerides (TGs), cholesterol (TC), and low-density lipoprotein-cholesterol (LDL-C) and decreased levels of high-density lipoprotein-cholesterol (HDL-C). It is a major public health issue with increased prevalence and incidence worldwide. The ability to identify individuals at risk of this disorder before symptoms manifest will facilitate timely intervention and management to avert potential complications. This can be achieved by employing metabolomics as an early detection method for the diagnostic biomarkers of hyperlipidemia. Metabolomics is an analytical approach used to detect and quantify metabolites. This provides the ability to explain the metabolic processes involved in the development and progression of certain diseases. In recent years, interest in the use of metabolomics to identify disease biomarkers has increased, and several biomarkers have been discovered, such as docosahexaenoic acid, glycocholic acid, citric acid, betaine, and carnitine. This review discusses the primary metabolic alterations in the context of hyperlipidemia. Furthermore, we provide an overview of recent studies on the application of metabolomics to the assessment of the efficacy of traditional herbal products and common lipid-lowering medications.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Faculty of Pharmacy, Al-Zaytoonah University of Jordan, Amman 17138, Jordan.
ORCID-Profile: Haneen Abuzaid
Förderung
- Al-Zaytoonah University of Jordan
Zitieren
APA
Alwahsh, M., Alejel, R., Hasan, A., Abuzaid, H., & Al-Qirim, T. (2024). The Application of Metabolomics in Hyperlipidemia: Insights into Biomarker Discovery and Treatment Efficacy Assessment. Metabolites, 14(8), 438. https://doi.org/10.3390/metabo14080438
Vancouver
Alwahsh M, Alejel R, Hasan A, Abuzaid H, Al-Qirim T. The Application of Metabolomics in Hyperlipidemia: Insights into Biomarker Discovery and Treatment Efficacy Assessment. Metabolites. 2024;14(8):438. doi:10.3390/metabo14080438
BibTeX
@article{Alwahsh2024,
author = {Alwahsh, Mohammad and Alejel, Rahaf and Hasan, Aya and Abuzaid, Haneen and Al-Qirim, Tariq},
title = {The Application of Metabolomics in Hyperlipidemia: Insights into Biomarker Discovery and Treatment Efficacy Assessment},
journal = {Metabolites},
year = {2024},
volume = {14},
number = {8},
pages = {438},
doi = {10.3390/metabo14080438}
}
EUVIMED